Search research articles
Contact Us
Filters
Showing results (241-250 of 284) with videos related to
Page
of 29
Sort By:
Blood Advances
|
April 22, 2026
Clinical variability of ATP11C-related hemolytic anemia: expanding the phenotypic and diagnostic spectrum
Vanessa D'Onofrio, Federica Maria Esposito, Roberta Marra, et al.
Journal of Neurology
|
October 19, 2014
Long-term outcome of epilepsy in patients with Prader-Willi syndrome
Alberto Verrotti, Raffaella Cusmai, Daniela Laino, et al.
The Journal of Dermatological Treatment
|
October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Psoriasis (Auckland, N.Z.)
|
September 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Molecular Psychiatry
|
March 24, 2026
Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials
Stefano Damiani, Riccardo Stefanelli, Lydia Fortea, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
August 5, 2015
Refractory absence seizures: An Italian multicenter retrospective study
Emilio Franzoni, Sara Matricardi, Veronica Di Pisa, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 284) with videos related to
Sort By:
Page
of 29
Blood Advances
|
April 22, 2026
Clinical variability of ATP11C-related hemolytic anemia: expanding the phenotypic and diagnostic spectrum
Vanessa D'Onofrio, Federica Maria Esposito, Roberta Marra, et al.
Journal of Neurology
|
October 19, 2014
Long-term outcome of epilepsy in patients with Prader-Willi syndrome
Alberto Verrotti, Raffaella Cusmai, Daniela Laino, et al.
The Journal of Dermatological Treatment
|
October 27, 2024
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, et al.
Dermatology and Therapy
|
January 23, 2025
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Federico Diotallevi, Maria Esposito, Maria Concetta Fargnoli, et al.
Psoriasis (Auckland, N.Z.)
|
September 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Expert Opinion on Biological Therapy
|
June 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, et al.
Molecular Psychiatry
|
March 24, 2026
Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials
Stefano Damiani, Riccardo Stefanelli, Lydia Fortea, et al.
Dermatology and Therapy
|
April 16, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
Clinical and Experimental Dermatology
|
April 16, 2025
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study
Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
August 5, 2015
Refractory absence seizures: An Italian multicenter retrospective study
Emilio Franzoni, Sara Matricardi, Veronica Di Pisa, et al.
Page
of 29